Marksans Pharma is engaged in the Business of Formulation of pharmaceutical products. Financial Results: Marksans Pharma Ltd reported Revenues for Q3FY24 of
Marksans Pharma Limited
-(MARKSANS)
XNSE:MAPMYINDIA, XBOM:MAPMYINDIA
Marksans Pharma Limited Q2 FY24 Earnings Conference Call Insights
Key highlights from Marksans Pharma Limited (MARKSANS) Q2 FY24 Earnings Concall Financial Performance Revenues grew 17% year-on-year to INR531 crores in Q2
Marksans Pharma Ltd Q1FY24; 17% rise in Profits
Marksans Pharma is engaged in the Business of Formulation of pharmaceutical products. Financial Results: Marksans Pharma Ltd reported Revenues for Q1FY24 of
Marksans Pharma Limited Q3 FY23 Earnings Conference Call Insights
Key highlights from Marksans Pharma Limited (MARKSANS) Q3 FY23 Earnings Concall Q&A Highlights: [00:08:54] Riddhesh Gandhi from Discovery Capital asked why there
Marksans Pharma Limited (MARKSANS) Q3 FY23 Earnings Concall Transcript
Marksans Pharma Limited (NSE:MARKSANS) Q3 FY23 Earnings Concall dated Feb. 14, 2023. Corporate Participants: Mark Saldanha -- Managing Director and Chief Executive Officer Jitendra
Marksans Pharma(NSE:MARKSANS): Everything You Need to Know | Stock up 30% in 3 Months
Marksans Pharma (NSE:MARKSANS) is a mid-sized pharmaceutical company with a large presence in the US, UK, Australia, and New Zealand markets. forward-integrated
Marksans Pharma Limited Q2 FY23 Earnings Conference Call Insights
Key highlights from Marksans Pharma Limited (MARKSANS) Q2 FY23 Earnings Concall Q&A Highlights: [00:12:45] Madhav Shastri asked about the new acquisition made
Marksans Pharma Limited Q1 FY23 Earnings Conference Call Insights
https://youtu.be/9PAJ7vTTG5E Key highlights from Marksans Pharma Limited (MARKSANS) Q1 FY23 Earnings Concall Management Update: MARKSANS said it aims to increase its R&D
Marksans Pharma Limited Q4 FY22 Earnings Conference Call Insights
Key highlights from Marksans Pharma Limited (MARKSANS) Q4 FY22 Earnings Concall Q&A Highlights: Vijay Nahar - Individual Investor - Analyst Challenges